DekaBank Deutsche Girozentrale’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.09M Hold
57,000
﹤0.01% 736
2025
Q1
$2.13M Hold
57,000
﹤0.01% 720
2024
Q4
$2.45M Hold
57,000
﹤0.01% 706
2024
Q3
$3.09M Hold
57,000
0.01% 677
2024
Q2
$2.36M Hold
57,000
﹤0.01% 733
2024
Q1
$2.66M Hold
57,000
0.01% 702
2023
Q4
$2.75M Buy
57,000
+17,000
+43% +$819K 0.01% 711
2023
Q3
$1.41M Hold
40,000
﹤0.01% 814
2023
Q2
$1.87M Buy
40,000
+10,000
+33% +$467K ﹤0.01% 763
2023
Q1
$1.15M Hold
30,000
﹤0.01% 839
2022
Q4
$1.35M Hold
30,000
﹤0.01% 811
2022
Q3
$1.21M Sell
30,000
-10,360
-26% -$418K ﹤0.01% 825
2022
Q2
$2.41M Sell
40,360
-1,000
-2% -$59.6K 0.01% 685
2022
Q1
$2.95M Hold
41,360
0.01% 673
2021
Q4
$3.43M Buy
41,360
+6,450
+18% +$534K 0.01% 654
2021
Q3
$3.01M Buy
34,910
+18,000
+106% +$1.55M 0.01% 642
2021
Q2
$1.62M Hold
16,910
﹤0.01% 777
2021
Q1
$1.9M Hold
16,910
0.01% 709
2020
Q4
$2.48M Sell
16,910
-1,540
-8% -$225K 0.01% 620
2020
Q3
$1.56M Buy
+18,450
New +$1.56M 0.01% 644
2019
Q4
Sell
-25,250
Closed -$1.07M 1207
2019
Q3
$1.07M Sell
25,250
-57,750
-70% -$2.45M 0.01% 654
2019
Q2
$5.15M Buy
+83,000
New +$5.15M 0.03% 418
2019
Q1
Sell
-20,000
Closed -$840K 1245
2018
Q4
$840K Buy
+20,000
New +$840K 0.01% 726
2018
Q2
Sell
-40,920
Closed -$2.06M 1238
2018
Q1
$2.06M Buy
40,920
+17,600
+75% +$887K 0.01% 564
2017
Q4
$1.43M Hold
23,320
0.01% 617
2017
Q3
$1.43M Hold
23,320
0.01% 625
2017
Q2
$1.44M Hold
23,320
0.01% 617
2017
Q1
$1.57M Sell
23,320
-4,500
-16% -$303K 0.01% 531
2016
Q4
$1.98M Sell
27,820
-6,900
-20% -$491K 0.02% 447
2016
Q3
$2.38M Sell
34,720
-25,000
-42% -$1.71M 0.03% 427
2016
Q2
$2.97M Buy
59,720
+41,200
+222% +$2.05M 0.03% 395
2016
Q1
$1.06M Sell
18,520
-1,150
-6% -$65.9K 0.01% 538
2015
Q4
$2.22M Buy
19,670
+1,610
+9% +$182K 0.03% 443
2015
Q3
$1.74M Buy
18,060
+1,060
+6% +$102K 0.02% 467
2015
Q2
$1.74M Buy
17,000
+600
+4% +$61.4K 0.02% 472
2015
Q1
$1.02M Buy
+16,400
New +$1.02M 0.01% 571